Navigation Links
Versailles Group Announces Accentus, Inc. Acquired by High Road Capital Partners
Date:4/21/2009

BOSTON, April 21 /PRNewswire/ -- Versailles Group, Ltd. (http://www.versaillesgroup.com) announced today Accentus, Inc. (http://www.accentus.ca) has been acquired by High Road Capital Partners (http://www.highroadcap.com) of New York.

Based in Ottawa, Ontario, Accentus is the largest provider in the Canadian outsourced medical transcription industry. Accentus provides medical transcription and editing services to over half of all hospitals, clinics, and independent physician groups throughout Canada.

Versailles Group, a 22-year-old Boston-based investment bank that specializes in international mergers, acquisitions, and divestitures, advised Accentus' shareholders on the transaction. Versailles Group has worked with companies in the U.S., Europe, Canada, and Latin America.

"With more than two decades of experience, Versailles Group is the expert in finding the right buyer for its domestic and international clients," said Don Grava, founder and president. "We are pleased that we successfully did so for Accentus."

"Accentus has been a leader in its industry for nearly a decade," he said. "When owners Steve and Rod Rogers retained Versailles Group for their divestiture, they knew that the combination of Versailles Group's skill and Accentus' performance would net them a superior valuation and a successful transaction. The clients' expectations were surpassed."

Versailles Group had previously sold two other businesses for the Rogers Family, Taima Corporation to Convergys Corporation and The PSC Communications Group Inc. to MacDonald Dettwiler & Associates.

Stephen Rogers, CEO of Accentus, and a significant investor in the divestiture along with brother and president Roderick Rogers, said, "Accentus has played a key role in developing the market for outsourced medical transcription and editing services in Canada." Rogers said that he and his brother "saw tremendous opportunity to accelerate Accentus' growth in partnership with High Road while continuing to provide exceptional service to our customers."

Senior debt financing for the transaction was provided by Bank of Montreal. Subordinated debt financing was provided by Bank of Montreal Capital Corporation, which invested along with High Road and Accentus management.

Transaction consideration was not disclosed.

Versailles Group, Ltd.

Versailles Group, Ltd. is a Boston-based investment bank that specializes in international mergers, acquisitions, and divestitures. Versailles Group's skill, flexibility, and experience have enabled it to successfully close transactions in any economic environment. More information on Versailles Group can be found on its website, http://www.versaillesgroup.com.

    For more information:

    Donald Grava (617) 449-3325
    dgrava@versaillesgroup.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Versailles Group, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Broad-based group of physicians calls for improvement in stroke treatment
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
4. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
5. New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group
6. AMERIGROUP to Acquire Memphis Health Plan
7. Securians Minnesota Life Continues to Climb Group Life Rankings
8. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
9. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
10. Group B Strep: A Threat to Newborns That Doesnt Have to Be
11. Cynosure to Present at the Maxim Group Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... Qualis Health, one of the ... 8th Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs ... across multiple award categories, highlighting four of the organization’s current programs:, ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... operations executives and focusing on all facets of clinical trial planning and management. ... , patient engagement, and more. In addition, attendees stopping by Pharmica’s booth were ...
(Date:2/17/2017)... ... 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists from around the ... - 23 in Beaver Creek, CO. It was announced today by Cindy Lovelace, executive ... Beaver Creek, hosting over 60 faculty members and addressing unmet needs of the NET ...
(Date:2/16/2017)... ... February 17, 2017 , ... ... last long after their final treatments. Physician researchers at The Marcus Institute ... a mind-body therapy, for efficacy in reducing symptoms of traumatic stress in cancer ...
(Date:2/16/2017)... ... February 16, 2017 , ... Doctors on Liens is proud ... their network through his work at BKP Chiropractic in Lancaster . ... degree from Canada’s prestigious International Baccalaureate Program, Dr. Raj went on to open ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , February 17, 2017 Cryoablation, Electrical, ... The global ablation technologies market is expected to grow ... from 2022-2027. The market is expected to grow at a CAGR ... $3.3bn in 2016, and $9.05bn in 2026. ... How this report will benefit you ...
(Date:2/17/2017)... , February 17, 2017 According to ... Particle Counters, Liquid Particle Counters), Application (Cleanroom Monitoring, Contamination Monitoring of ... to 2021" published by MarketsandMarkets, the market is expected to reach ... at a CAGR of 3.7% from 2016 to 2021. ... ...
(Date:2/17/2017)... 17, 2017 Theravance Biopharma, Inc. (NASDAQ: ... "Company") today announced the presentation of positive clinical ... administered pan-Janus kinase (JAK) inhibitor designed to be ... of the European Crohn,s and Colitis Organization (ECCO). ... data from its completed Phase 1 study of ...
Breaking Medicine Technology: